Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer
- PMID: 1653178
- PMCID: PMC1378963
- DOI: 10.1136/gut.32.8.923
Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer
Abstract
Short chain (C2-C6) fatty acids are produced in the colon through bacterial fermentation of mainly dietary fibre. Butyrate (C4) possesses antineoplastic effects on human colon carcinoma cells, and epidemiological studies indicate that high fibre diets may reduce the incidence of colorectal cancer. The role of dietary fibre during colorectal carcinogenesis might therefore be related to its fermentation to butyrate. Faecal concentrations of total short chain fatty acids and concentrations and ratios of the individual C2-C6 fatty acids did not differ between 16 healthy controls, 17 patients with colonic adenomas, and 17 patients with colonic cancer. Comparison of the molar production velocities (mmol/l.hour) of total and individual short chain fatty acids from glucose, ispagula, wheat bran, and albumin in six and 24 hour faecal incubations showed no differences. The ratio of butyrate production to total short chain fatty acid production from fibre, however, was reduced in patients with colonic cancer and adenomas compared with healthy controls (ispagula, six hours: 6.4, 7.6, and 11.5% respectively, p = 0.005 and 24 hour: 9.1, 9.9, and 15.4%, p = 0.002; wheat bran, six hours: 9.9, 10.2, and 14.7% respectively, p = 0.06 and 24 hours: 15.1, 16.8, and 21.0%, p = 0.01). It may be that the low ratios of colonic butyrate formation combined with low fibre diets increase the risk of colonic neoplasia.
Similar articles
-
Colonic fermentation of ispaghula, wheat bran, glucose, and albumin to short-chain fatty acids and ammonia evaluated in vitro in 50 subjects.JPEN J Parenter Enteral Nutr. 1992 Sep-Oct;16(5):433-9. doi: 10.1177/0148607192016005433. JPEN J Parenter Enteral Nutr. 1992. PMID: 1331553
-
Colonic production of butyrate in patients with previous colonic cancer during long-term treatment with dietary fibre (Plantago ovata seeds).Scand J Gastroenterol. 1996 Oct;31(10):1011-20. doi: 10.3109/00365529609003122. Scand J Gastroenterol. 1996. PMID: 8898423
-
Short-chain fatty acids produced in vitro from fibre residues obtained from mixed diets containing different breads and in human faeces during the ingestion of the diets.Br J Nutr. 2000 Jul;84(1):31-7. Br J Nutr. 2000. PMID: 10961158
-
Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre.Mutat Res. 2009 Jul-Aug;682(1):39-53. doi: 10.1016/j.mrrev.2009.04.001. Epub 2009 Apr 19. Mutat Res. 2009. PMID: 19383551 Review.
-
Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.Scand J Gastroenterol Suppl. 1996;216:132-48. doi: 10.3109/00365529609094568. Scand J Gastroenterol Suppl. 1996. PMID: 8726286 Review.
Cited by
-
The characterization of butyrate transport across pig and human colonic luminal membrane.J Physiol. 1998 Mar 15;507 ( Pt 3)(Pt 3):819-30. doi: 10.1111/j.1469-7793.1998.819bs.x. J Physiol. 1998. PMID: 9508842 Free PMC article.
-
Changes of fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon.Appl Environ Microbiol. 1999 Jul;65(7):2807-12. doi: 10.1128/AEM.65.7.2807-2812.1999. Appl Environ Microbiol. 1999. PMID: 10388668 Free PMC article. Clinical Trial.
-
Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.Future Oncol. 2010 Jan;6(1):127-48. doi: 10.2217/fon.09.145. Future Oncol. 2010. PMID: 20021214 Free PMC article. Review.
-
Wheat bran: its composition and benefits to health, a European perspective.Int J Food Sci Nutr. 2012 Dec;63(8):1001-13. doi: 10.3109/09637486.2012.687366. Epub 2012 Jun 20. Int J Food Sci Nutr. 2012. PMID: 22716911 Free PMC article. Review.
-
The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer.Prz Gastroenterol. 2024;19(2):121-126. doi: 10.5114/pg.2024.139209. Epub 2024 Apr 29. Prz Gastroenterol. 2024. PMID: 38939069 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous